- Depression is characterized by loss of interest and pleasure in activities, and is thought to involve decreased activity of neurotransmitters like serotonin and norepinephrine in the brain.
- Major classes of antidepressants include tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and heterocyclic antidepressants.
- TCAs and SNRIs work by inhibiting the reuptake of serotonin and norepinephrine, while SSRIs selectively inhibit serotonin reuptake. MAOIs inhibit the enzyme monoamine oxidase responsible for breaking down monoamine neurotransmitters
This document summarizes a lecture on clinical depression and antidepressants. It discusses the classification, mechanisms of action, indications, and side effects of various classes of antidepressants including tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs). It also covers the symptoms and comorbidities of clinical depression as well as the delayed onset of antidepressant effect.
Premedication involves both psychological preparation of the patient through discussion as well as administration of drugs to reduce anxiety, provide sedation and analgesia, and decrease anesthetic requirements. Common drugs given orally or intramuscularly 1-2 hours before induction include benzodiazepines like lorazepam and midazolam, opioids like morphine and meperidine, barbiturates like secobarbital and pentobarbital, and antacids. The goals of premedication are to reduce anxiety, provide sedation and analgesia, induce amnesia, decrease sympathetic responses, and prevent postoperative nausea and vomiting.
The document discusses various classes of psychotropic medications used to treat mental health conditions. It covers antipsychotics, antidepressants, mood stabilizers, medications for ADHD, and sedative-hypnotics. Key principles of psychopharmacotherapy are diagnostic assessment, insufficiency of medication alone, importance of illness phase, and risk-benefit considerations in treatment strategies.
This document discusses types of depression, symptoms, diagnosis, causes and treatment options. It describes major depression, chronic depression, atypical depression and bipolar disorder. Symptoms include persistent sadness, loss of pleasure, changes in appetite and sleep. Diagnosis involves patient history, blood tests and DSM-IV criteria. Causes may include genetics, death, abuse and medications. Treatments include psychotherapy, electroconvulsive therapy, medications like SSRIs, SNRIs, TCAs and MAOIs which work by inhibiting reuptake of neurotransmitters like serotonin and norepinephrine. Side effects of medications are also discussed.
This document discusses antidepressants and the pathophysiology of depression. It describes different types of antidepressant drugs, including monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs). It discusses several hypotheses for the pathophysiology of depression related to neurotrophic factors, neuroendocrine systems, and the interactions between monoamine systems, HPA axis, and neurotrophic factors like BDNF. The document also provides details on the mechanisms of action, pharmacokinetics, pharmacological effects, and side effects of MAOIs as one class of antidepressant drugs.
David studied neurological disorders like Parkinson's disease and schizophrenia to gain a wider understanding of involved drugs and their targets. He summarized information on major depressive disorder (MDD) and the antidepressant drug Citalopram. MDD is a common mental illness associated with reduced quality of life and increased suicide risk. Citalopram is a selective serotonin reuptake inhibitor used to treat MDD by increasing synaptic serotonin levels. However, some patients do not respond to SSRIs and they have a delayed onset of action leading to discontinuation of treatment for many. Combining SSRIs with 5HT receptor antagonists may improve efficacy and reduce discontinuation.
- Depression is characterized by loss of interest and pleasure in activities, and is thought to involve decreased activity of neurotransmitters like serotonin and norepinephrine in the brain.
- Major classes of antidepressants include tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), and heterocyclic antidepressants.
- TCAs and SNRIs work by inhibiting the reuptake of serotonin and norepinephrine, while SSRIs selectively inhibit serotonin reuptake. MAOIs inhibit the enzyme monoamine oxidase responsible for breaking down monoamine neurotransmitters
This document summarizes a lecture on clinical depression and antidepressants. It discusses the classification, mechanisms of action, indications, and side effects of various classes of antidepressants including tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs). It also covers the symptoms and comorbidities of clinical depression as well as the delayed onset of antidepressant effect.
Premedication involves both psychological preparation of the patient through discussion as well as administration of drugs to reduce anxiety, provide sedation and analgesia, and decrease anesthetic requirements. Common drugs given orally or intramuscularly 1-2 hours before induction include benzodiazepines like lorazepam and midazolam, opioids like morphine and meperidine, barbiturates like secobarbital and pentobarbital, and antacids. The goals of premedication are to reduce anxiety, provide sedation and analgesia, induce amnesia, decrease sympathetic responses, and prevent postoperative nausea and vomiting.
The document discusses various classes of psychotropic medications used to treat mental health conditions. It covers antipsychotics, antidepressants, mood stabilizers, medications for ADHD, and sedative-hypnotics. Key principles of psychopharmacotherapy are diagnostic assessment, insufficiency of medication alone, importance of illness phase, and risk-benefit considerations in treatment strategies.
This document discusses types of depression, symptoms, diagnosis, causes and treatment options. It describes major depression, chronic depression, atypical depression and bipolar disorder. Symptoms include persistent sadness, loss of pleasure, changes in appetite and sleep. Diagnosis involves patient history, blood tests and DSM-IV criteria. Causes may include genetics, death, abuse and medications. Treatments include psychotherapy, electroconvulsive therapy, medications like SSRIs, SNRIs, TCAs and MAOIs which work by inhibiting reuptake of neurotransmitters like serotonin and norepinephrine. Side effects of medications are also discussed.
This document discusses antidepressants and the pathophysiology of depression. It describes different types of antidepressant drugs, including monoamine oxidase inhibitors (MAOIs) and selective serotonin reuptake inhibitors (SSRIs). It discusses several hypotheses for the pathophysiology of depression related to neurotrophic factors, neuroendocrine systems, and the interactions between monoamine systems, HPA axis, and neurotrophic factors like BDNF. The document also provides details on the mechanisms of action, pharmacokinetics, pharmacological effects, and side effects of MAOIs as one class of antidepressant drugs.
David studied neurological disorders like Parkinson's disease and schizophrenia to gain a wider understanding of involved drugs and their targets. He summarized information on major depressive disorder (MDD) and the antidepressant drug Citalopram. MDD is a common mental illness associated with reduced quality of life and increased suicide risk. Citalopram is a selective serotonin reuptake inhibitor used to treat MDD by increasing synaptic serotonin levels. However, some patients do not respond to SSRIs and they have a delayed onset of action leading to discontinuation of treatment for many. Combining SSRIs with 5HT receptor antagonists may improve efficacy and reduce discontinuation.
This document summarizes the diagnosis and treatment plan for a 60-year-old male patient presenting with anxiety symptoms including palpitations, sweating, giddiness and numbness. After examination, the patient was diagnosed with anxiety. The treatment plan involves prescribing the benzodiazepine clonazepam to enhance GABA activity, the NSAID naproxen to inhibit prostaglandin synthesis and reduce inflammation, the antiemetic ondansetron to block serotonin receptors, and the proton pump inhibitor pantoprazole to inhibit gastric acid production. Patient counseling includes avoiding alcohol, quitting smoking, limiting caffeine, reducing stress, meditating, and staying physically active.
The document discusses depression, including that it is a serious mood disorder that can affect people of all ages and backgrounds. Depression comes in several types, such as unipolar which involves mood swings in one direction, and bipolar which involves periods of depression and mania. The causes of depression include genetics, medication, substance use, medical conditions, and life events. Treatments include psychotherapy, electroconvulsive therapy, natural alternatives, and antidepressant medications. The document focuses on antidepressant medications, describing the different classes including tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, atypical antidepressants, and monoamine oxidase inhibitors. It provides examples of medications in
Methamphetamine is a stimulant that comes in powder or crystal form and can be injected, snorted, smoked, or taken orally. It causes increased alertness but also symptoms like agitation, increased heart rate and blood pressure, sweating, and potential for hyperthermia or psychosis. Treatment involves sedation with benzodiazepines to control agitation, treating hyperthermia and hypertension aggressively, and watching for complications like rhabdomyolysis or associated injuries. Methamphetamine users may also be at risk of contamination from toxic chemicals from production sites and can present a risk of violence.
CNS-Definition, Classification, Different classes of drug acting on CNS
General Anesthetic- Definition, Stages of anesthesia, Classification
Anesthetic drug- Thiopentone sodium, Ketamine, Propofol detailed study
Anti psychotic and antidepressant drugsSubhayan Das
This document discusses psychiatric illnesses and the drugs used to treat them. It describes the main types of psychiatric conditions like psychosis, neurosis, schizophrenia, mood disorders, anxiety disorders and PTSD. It then summarizes the two major types of antipsychotic drugs - typical and atypical - and their side effect profiles. Next, it covers depression and the various classes of antidepressant drugs including SSRIs, SNRIs, TCAs and atypicals. It also discusses the uses of lithium and newer drugs like esketamine, brexanolone and pimavanserin.
This document discusses various psychotropic medications including their classifications, mechanisms of action, indications, side effects and nursing implications. It covers antianxiety agents, sedative-hypnotics, mood stabilizers, antipsychotics, antidepressants and ADHD medications. Nurses must understand how to properly administer these medications and monitor for both therapeutic effects and potential adverse reactions. Psychotropic medications can help relieve symptoms but do not cure the underlying mental illness.
This document discusses various types of antidepressant and mood stabilizing medications. It begins by describing two main types of depression - unipolar and bipolar disorder. It then lists and describes several classes of antidepressants including SSRIs, TCAs, MAO inhibitors, and atypical antidepressants. Specific medications are provided within each class along with typical dosages. Adverse effects of TCAs are outlined. The mechanisms of action of various antidepressants are explained. Mood stabilizers for bipolar disorder such as lithium, valproate, lamotrigine, and carbamazepine are then discussed along with their pharmacokinetic properties and disadvantages.
This document discusses anxiolytics, or anti-anxiety drugs. It defines anxiety and differentiates it from fear. It outlines the learning objectives which are to define key terms, list classes of anxiolytic drugs, and describe the mechanisms of action, effects, pharmacokinetics, adverse effects, and interactions of anxiolytics. The major classes of anxiolytics discussed are benzodiazepines, azapirones, and beta-blockers. Benzodiazepines are described as the most important sedative-hypnotics, with properties including a wide margin of safety but risk of dependence with prolonged use. Buspirone is discussed as an azapirone anxi
- An antidepressant medication is recommended as the initial treatment for mild to moderate major depressive disorder (MDD) and is definitely recommended for severe MDD. Selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), mirtazapine, or bupropion are optimal first choices.
- Factors like chronicity, severity, melancholic features, and comorbidities can help predict treatment response and determine the best subsequent treatment steps if the initial treatment is inadequate. Treatment should be optimized at each step by considering dose increases, switches, combinations, or augmentations based on the individual patient.
- Measurement-based care and identifying prognostic and prescript
Hydromorphone is an opioid agonist analgesic that is approximately 5-7 times more potent than morphine. It comes in both immediate and sustained release formulations for oral administration, as well as injectable formulations. Special precautions should be taken when prescribing hydromorphone for elderly patients, those with CNS depression risk factors, or those with conditions like epilepsy that increase seizure risk. Common side effects include nausea, vomiting, drowsiness, and constipation.
Serotonin syndrome is a potentially life-threatening adverse drug reaction that results from excess serotonin activity in the central nervous system. It most commonly occurs when two or more serotonergic drugs are taken together, such as a combination of antidepressants. Symptoms range from tremors and diarrhea in mild cases to delirium, muscle rigidity, and hyperthermia in more severe cases. Treatment involves discontinuing the precipitating drugs, providing supportive care, and administering drugs that block serotonin receptors like cyproheptadine to counteract excess serotonin activity. Prevention relies on awareness of potential drug interactions and avoiding unnecessary combinations of serotonergic medications.
This document summarizes different types of anticonvulsants used to treat epilepsy and seizure disorders. It discusses their mechanisms of action, classifications, and structure-activity relationships. The main classes covered are barbiturates, hydantoins, oxazolidinediones, succinimides, ureas, benzodiazepines, and some miscellaneous anticonvulsants like primidone, valproic acid, gabapentin, and felbamate. Each class is explained in terms of prototypical drugs, their structures, metabolic pathways, and indications for use in treating seizures.
This document discusses the use of SSRIs and SNRIs for pain control. It reviews several studies that have investigated the effects of various SSRIs (citalopram, escitalopram, paroxetine, fluoxetine, sertraline) and SNRIs (duloxetine, venlafaxine) on chronic pain conditions. While many studies found positive effects of SSRIs on pain, the results were inconsistent and inconclusive. Larger and higher quality studies are still needed. Duloxetine is the only antidepressant approved for neuropathic pain. Venlafaxine and duloxetine, which affect both serotonin and norepinephrine, showed efficacy in pain management.
Sedatives and hypnotics act on the central nervous system to reduce anxiety and promote sleep. Benzodiazepines are the most commonly used class, enhancing the effect of the inhibitory neurotransmitter GABA. They have sedative, anxiolytic, muscle relaxing, and anticonvulsant effects. While effective, they can cause tolerance, dependence, and withdrawal symptoms with long-term use. The ideal hypnotic would have rapid onset, sustained nighttime effects, and no morning residual effects, but this is difficult to achieve without risk of rebound insomnia or withdrawal.
This document summarizes various psych drugs including antidepressants, mood stabilizers, antipsychotics, and anxiolytics/hypnotics. It describes how antidepressants like SSRIs work to increase serotonin and norepinephrine levels. It also discusses the mechanisms and side effects of different classes of antidepressants and mood stabilizers. The summary outlines conventional and atypical antipsychotics indicating their uses and side effects. Finally, it reviews anxiolytic benzodiazepines and their therapeutic indications as well as risks like dependence.
This document discusses different types of phobias, including omphalophobia which is the fear of belly buttons, nomophobia which is the fear of not having a mobile phone or service, and anatidaephobia which is the fear that somewhere a duck is watching you. It also mentions influences and effects of phobias such as anxiety, distress, and avoidance. The document provides examples of uncommon phobias like the fear of big words, laughter, ideas, and even phobias themselves.
This document summarizes different classes of drugs used to treat depression, including SSRIs, SNRIs, TCAs, MAOIs, and atypical antidepressants. It describes the mechanisms of action, therapeutic uses, examples of drugs, and potential adverse effects for each class. Key points covered include that SSRIs work by inhibiting serotonin reuptake and it takes 4-6 weeks to see effects, TCAs also inhibit norepinephrine reuptake and are used for depression with accompanying pain, and MAOIs non-selectively inhibit MAO enzymes and their use requires avoiding foods high in tyramine to prevent dangerous interactions.
This document summarizes the diagnosis and treatment plan for a 60-year-old male patient presenting with anxiety symptoms including palpitations, sweating, giddiness and numbness. After examination, the patient was diagnosed with anxiety. The treatment plan involves prescribing the benzodiazepine clonazepam to enhance GABA activity, the NSAID naproxen to inhibit prostaglandin synthesis and reduce inflammation, the antiemetic ondansetron to block serotonin receptors, and the proton pump inhibitor pantoprazole to inhibit gastric acid production. Patient counseling includes avoiding alcohol, quitting smoking, limiting caffeine, reducing stress, meditating, and staying physically active.
The document discusses depression, including that it is a serious mood disorder that can affect people of all ages and backgrounds. Depression comes in several types, such as unipolar which involves mood swings in one direction, and bipolar which involves periods of depression and mania. The causes of depression include genetics, medication, substance use, medical conditions, and life events. Treatments include psychotherapy, electroconvulsive therapy, natural alternatives, and antidepressant medications. The document focuses on antidepressant medications, describing the different classes including tricyclic antidepressants, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, atypical antidepressants, and monoamine oxidase inhibitors. It provides examples of medications in
Methamphetamine is a stimulant that comes in powder or crystal form and can be injected, snorted, smoked, or taken orally. It causes increased alertness but also symptoms like agitation, increased heart rate and blood pressure, sweating, and potential for hyperthermia or psychosis. Treatment involves sedation with benzodiazepines to control agitation, treating hyperthermia and hypertension aggressively, and watching for complications like rhabdomyolysis or associated injuries. Methamphetamine users may also be at risk of contamination from toxic chemicals from production sites and can present a risk of violence.
CNS-Definition, Classification, Different classes of drug acting on CNS
General Anesthetic- Definition, Stages of anesthesia, Classification
Anesthetic drug- Thiopentone sodium, Ketamine, Propofol detailed study
Anti psychotic and antidepressant drugsSubhayan Das
This document discusses psychiatric illnesses and the drugs used to treat them. It describes the main types of psychiatric conditions like psychosis, neurosis, schizophrenia, mood disorders, anxiety disorders and PTSD. It then summarizes the two major types of antipsychotic drugs - typical and atypical - and their side effect profiles. Next, it covers depression and the various classes of antidepressant drugs including SSRIs, SNRIs, TCAs and atypicals. It also discusses the uses of lithium and newer drugs like esketamine, brexanolone and pimavanserin.
This document discusses various psychotropic medications including their classifications, mechanisms of action, indications, side effects and nursing implications. It covers antianxiety agents, sedative-hypnotics, mood stabilizers, antipsychotics, antidepressants and ADHD medications. Nurses must understand how to properly administer these medications and monitor for both therapeutic effects and potential adverse reactions. Psychotropic medications can help relieve symptoms but do not cure the underlying mental illness.
This document discusses various types of antidepressant and mood stabilizing medications. It begins by describing two main types of depression - unipolar and bipolar disorder. It then lists and describes several classes of antidepressants including SSRIs, TCAs, MAO inhibitors, and atypical antidepressants. Specific medications are provided within each class along with typical dosages. Adverse effects of TCAs are outlined. The mechanisms of action of various antidepressants are explained. Mood stabilizers for bipolar disorder such as lithium, valproate, lamotrigine, and carbamazepine are then discussed along with their pharmacokinetic properties and disadvantages.
This document discusses anxiolytics, or anti-anxiety drugs. It defines anxiety and differentiates it from fear. It outlines the learning objectives which are to define key terms, list classes of anxiolytic drugs, and describe the mechanisms of action, effects, pharmacokinetics, adverse effects, and interactions of anxiolytics. The major classes of anxiolytics discussed are benzodiazepines, azapirones, and beta-blockers. Benzodiazepines are described as the most important sedative-hypnotics, with properties including a wide margin of safety but risk of dependence with prolonged use. Buspirone is discussed as an azapirone anxi
- An antidepressant medication is recommended as the initial treatment for mild to moderate major depressive disorder (MDD) and is definitely recommended for severe MDD. Selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), mirtazapine, or bupropion are optimal first choices.
- Factors like chronicity, severity, melancholic features, and comorbidities can help predict treatment response and determine the best subsequent treatment steps if the initial treatment is inadequate. Treatment should be optimized at each step by considering dose increases, switches, combinations, or augmentations based on the individual patient.
- Measurement-based care and identifying prognostic and prescript
Hydromorphone is an opioid agonist analgesic that is approximately 5-7 times more potent than morphine. It comes in both immediate and sustained release formulations for oral administration, as well as injectable formulations. Special precautions should be taken when prescribing hydromorphone for elderly patients, those with CNS depression risk factors, or those with conditions like epilepsy that increase seizure risk. Common side effects include nausea, vomiting, drowsiness, and constipation.
Serotonin syndrome is a potentially life-threatening adverse drug reaction that results from excess serotonin activity in the central nervous system. It most commonly occurs when two or more serotonergic drugs are taken together, such as a combination of antidepressants. Symptoms range from tremors and diarrhea in mild cases to delirium, muscle rigidity, and hyperthermia in more severe cases. Treatment involves discontinuing the precipitating drugs, providing supportive care, and administering drugs that block serotonin receptors like cyproheptadine to counteract excess serotonin activity. Prevention relies on awareness of potential drug interactions and avoiding unnecessary combinations of serotonergic medications.
This document summarizes different types of anticonvulsants used to treat epilepsy and seizure disorders. It discusses their mechanisms of action, classifications, and structure-activity relationships. The main classes covered are barbiturates, hydantoins, oxazolidinediones, succinimides, ureas, benzodiazepines, and some miscellaneous anticonvulsants like primidone, valproic acid, gabapentin, and felbamate. Each class is explained in terms of prototypical drugs, their structures, metabolic pathways, and indications for use in treating seizures.
This document discusses the use of SSRIs and SNRIs for pain control. It reviews several studies that have investigated the effects of various SSRIs (citalopram, escitalopram, paroxetine, fluoxetine, sertraline) and SNRIs (duloxetine, venlafaxine) on chronic pain conditions. While many studies found positive effects of SSRIs on pain, the results were inconsistent and inconclusive. Larger and higher quality studies are still needed. Duloxetine is the only antidepressant approved for neuropathic pain. Venlafaxine and duloxetine, which affect both serotonin and norepinephrine, showed efficacy in pain management.
Sedatives and hypnotics act on the central nervous system to reduce anxiety and promote sleep. Benzodiazepines are the most commonly used class, enhancing the effect of the inhibitory neurotransmitter GABA. They have sedative, anxiolytic, muscle relaxing, and anticonvulsant effects. While effective, they can cause tolerance, dependence, and withdrawal symptoms with long-term use. The ideal hypnotic would have rapid onset, sustained nighttime effects, and no morning residual effects, but this is difficult to achieve without risk of rebound insomnia or withdrawal.
This document summarizes various psych drugs including antidepressants, mood stabilizers, antipsychotics, and anxiolytics/hypnotics. It describes how antidepressants like SSRIs work to increase serotonin and norepinephrine levels. It also discusses the mechanisms and side effects of different classes of antidepressants and mood stabilizers. The summary outlines conventional and atypical antipsychotics indicating their uses and side effects. Finally, it reviews anxiolytic benzodiazepines and their therapeutic indications as well as risks like dependence.
This document discusses different types of phobias, including omphalophobia which is the fear of belly buttons, nomophobia which is the fear of not having a mobile phone or service, and anatidaephobia which is the fear that somewhere a duck is watching you. It also mentions influences and effects of phobias such as anxiety, distress, and avoidance. The document provides examples of uncommon phobias like the fear of big words, laughter, ideas, and even phobias themselves.
This document summarizes different classes of drugs used to treat depression, including SSRIs, SNRIs, TCAs, MAOIs, and atypical antidepressants. It describes the mechanisms of action, therapeutic uses, examples of drugs, and potential adverse effects for each class. Key points covered include that SSRIs work by inhibiting serotonin reuptake and it takes 4-6 weeks to see effects, TCAs also inhibit norepinephrine reuptake and are used for depression with accompanying pain, and MAOIs non-selectively inhibit MAO enzymes and their use requires avoiding foods high in tyramine to prevent dangerous interactions.
This presentation along with a literature review of the same topic was my final project for my Advanced General Psychology capstone class at Argosy University. I am very passionate and interested in combination therapy and contextual therapeutic methods rather than the more common medical approach to treating depression. The therapeutic alliance and therapeutic process itself has substantial healing capabilities. Contextual treatments are more difficult to measure and less readily available than medical treatment. This presentation explores the issue.
This document summarizes several journal articles on treatment-resistant bipolar depression. It describes a randomized controlled trial that compared electroconvulsive therapy to algorithm-based pharmacological treatment. It also reviews evidence-based treatment strategies for treatment-resistant bipolar depression from previous systematic reviews. Additional sources included are a study protocol for a Norwegian randomized controlled trial of ECT for treatment-resistant depression in bipolar disorder, a systematic review on new treatment guidelines for acute bipolar depression, and an article on definitions and evidence-based treatment of refractoriness in bipolar disorder. The results section indicates the document analyzes treatment variables and methods of assessing outcomes in trials of interventions for treatment-resistant bipolar depression.
Dr. Shakir's CTF Presentation - Depression Treatmentdanjack11
This document discusses the latest advances in treating depression, including both pharmacological and non-pharmacological options. It mentions transcranial magnetic stimulation (TMS) as a non-invasive FDA-approved treatment for depression, and provides information about Silicon Valley TMS, a TMS provider. It also discusses challenges in diagnosing and treating depression, the neurobiology of depression, and how untreated depression can impact physical health. Current treatment options discussed include psychotherapy, electroconvulsive therapy, phototherapy, rapid TMS, vagus nerve stimulation, and antidepressant medications.
Antidepressants are the second most prescribed medication in the US, with 15 million Americans affected by depression each year. Depression is treated through medications and therapy. Antidepressants work by adjusting neurotransmitter levels in the brain like serotonin, dopamine, and norepinephrine. Common classes include SSRIs, SNRIs, TCAs, and MAOIs. While effective, antidepressants can cause side effects like nausea, insomnia, sexual dysfunction, and increased suicide risk initially. Doctors closely monitor patients to improve treatment outcomes and safety.
This document provides an overview of psychotropic medications used to treat various mental disorders. It defines psychotropic drugs as those used to treat mental disorders like depression, bipolar disorder, anxiety disorders, schizophrenia, and addiction. Various classes of antidepressants, mood stabilizers, and anti-anxiety medications are described along with their mechanisms of action and common side effects. The concept of depression, bipolar disorder, anxiety disorders, and addiction are defined. Combination therapies using medication and psychotherapy are noted to be most effective. Criticism of attributing a biological basis for mental illness based on existing drug studies is also mentioned.
This document provides an overview of psychotropic medications, which are medications used to treat mental disorders. It defines key terms and describes the psychiatric conditions of depression, bipolar disorder, and anxiety disorder. It then lists examples of medications that can be used to treat each condition, including antidepressants, mood stabilizers, and anti-anxiety medications. The document stresses that the most important message for pregnant or breastfeeding women is to discuss the risks and benefits of medication with their doctor. It identifies several web resources for more information.
This document discusses various types of antidepressants and antipsychotics used to treat mood disorders such as depression. It describes three types of depression - reactive, major, and bipolar disorder. It then covers different classes of antidepressants including tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), atypical antidepressants, and monoamine oxidase inhibitors (MAOIs). Side effects and contraindications of these drug classes are also outlined. The document also discusses antipsychotics used to treat psychosis and their classification into typical and atypical drugs. Extrapyramidal side effects of typical antipsychotics are noted.
This document discusses depression, including its causes, symptoms, diagnosis and treatment options. It describes two main types of depression - exogenous depression, which usually follows traumatic life events, and endogenous depression, which is not associated with precipitating events and may be due to biochemical changes. Common symptoms of depression are then listed. The document goes on to discuss various treatment approaches for depression, including psychotherapy, electroconvulsive therapy, and several classes of antidepressant medications like SSRIs, SNRIs, TCAs, MAOIs and others. Side effects and mechanisms of action are provided for some of the antidepressant classes.
1. Antidepressants work by increasing levels of neurotransmitters like serotonin and norepinephrine in the brain. They are divided into several classes including SSRIs, SNRIs, TCAs, and MAOIs.
2. SSRIs are now the most commonly prescribed due to their safer side effect profile. They work by inhibiting reuptake of serotonin. TCAs affect serotonin and norepinephrine but have more side effects.
3. Antidepressants take 2-3 weeks to start working and should be taken long term to prevent relapse of depression. Side effects are usually mild and transient but can include nausea, sexual dysfunction, and dry mouth depending on the drug class.
This document provides information on drugs used to treat depression. It begins by classifying various types of antidepressants including tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs). It then describes the pharmacological actions and side effects of these different classes of antidepressants. Finally, it discusses the clinical uses and limitations of antidepressant therapies in managing conditions like depression, anxiety disorders, and bipolar disorder.
DRUGS USED IN THE MANAGEMENT OF AFFECTIVE DISORDERS.pptxLevysikazwe
This document discusses drugs used in the management of affective disorders such as depression and bipolar disorder. It describes four classes of antidepressants - tricyclic antidepressants, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, and atypical antidepressants. It also discusses mood stabilizers like lithium, carbamazepine, and valproate that are used to treat bipolar disorder. Adverse effects, mechanisms of action, drug interactions, and contraindications are described for various antidepressant and mood stabilizing drugs.
anti depressants drugs for mbbs students pharmacology.pptpharmacologycmccbe
This document discusses antidepressant drugs and their mechanisms of action. It covers several topics:
1. It describes the monoamine neurotransmitter systems (serotonin, norepinephrine, dopamine) and how they are implicated in depression due to decreased activity.
2. It classifies and describes the symptoms of major depressive disorders.
3. It discusses the mechanisms of action, effects, and side effects of different classes of antidepressants including TCAs, SSRIs, atypical antidepressants, and MAOIs.
4. It also briefly discusses the uses of antidepressants for other conditions beyond depression and the treatment of bipolar disorder.
Depression is a mental illness characterized by changes in mood and loss of interest. It has several potential causes like abuse, loss, isolation, stress, or unemployment. There are different types of depression including unipolar, reactive, endogenous, and bipolar. Antidepressants work by increasing neurotransmitters like serotonin, norepinephrine, and dopamine in the brain. Common antidepressants include SSRIs, SNRIs, TCAs, and MAO inhibitors. SSRIs are now the first-line treatment due to their safer side effect profile compared to older TCAs.
The document discusses different types of depression including unipolar, bipolar, and endogenous depression. It also discusses mania, describing it as a pathological change in mood state with increased amine levels. The causes and symptoms of mania are outlined. The document then classifies and describes different types of antidepressant drugs including tricyclic antidepressants, selective serotonin reuptake inhibitors, atypical antidepressants, serotonin-norepinephrine reuptake inhibitors, and monoamine oxidase inhibitors. It discusses their mechanisms of action and side effects.
This document discusses depression, antidepressants, and bipolar disorder. It defines depression as characterized by sadness, changes in sleep/appetite, loss of energy, and suicidal thoughts. Antidepressants are classified into SSRIs, SNRIs, TCAs, MAOIs, and atypical types. SSRIs are commonly used to treat depression, anxiety disorders, OCD, and others. Common side effects include headaches, nausea, sexual dysfunction, and weight changes. SNRIs inhibit serotonin and norepinephrine reuptake and are used for depression, fibromyalgia, and other conditions. Bipolar disorder involves periods of depression and mania, and is treated with lithium or atypical antipsychotics like risper
Antidepressants work primarily by increasing levels of serotonin, norepinephrine, and dopamine in the brain. The most common classes are SSRIs, SNRIs, TCAs, and MAOIs. SSRIs are usually the first line treatment due to their efficacy and safety. They work by selectively inhibiting the reuptake of serotonin. SNRIs also inhibit norepinephrine reuptake. TCAs and MAOIs are less commonly used now due to their side effect profiles. Common side effects across classes include nausea, sleep disturbances, and sexual dysfunction.
This document discusses various classes of antidepressants and psychostimulants. It describes antidepressants such as TCAs, SSRIs, SNRIs, atypical antidepressants, and MAOIs. It details their mechanisms of action, examples of drugs in each class, effects, uses, and side effects. The document also covers psychostimulant drugs like amphetamines, their mechanisms in the brain and periphery, clinical uses to improve mood and increase alertness, and risks with long term use.
Depression is a mental health disorder.
Characterized by symptoms like sad mood, loss of interest and pleasure, low energy, worthlessness, guilt, psychomotor retardation or agitation, change in appetite and/ or sleep, melancholia, suicidal thoughts, etc.
It may be unipolar (only depression) or bipolar (cycle of mood swings from mania to depression).
It is the leading psychiatric disorder.
The mood change may have a psychotic basis with delusional thinking or occur in isolation.
Antidepresants are the drugs which can elevate mood in depressive illness.
The document discusses various classes of antidepressant drugs, including their mechanisms of action, pharmacological profiles, and clinical uses. It describes tricyclic antidepressants which inhibit the reuptake of serotonin and norepinephrine. Selective serotonin reuptake inhibitors like fluoxetine selectively block the reuptake of serotonin. Serotonin-norepinephrine reuptake inhibitors block the reabsorption of both neurotransmitters. Monoamine oxidase inhibitors prevent the breakdown of monoamines by inhibiting monoamine oxidase.
This document discusses depression and its treatment with antidepressants. It first defines depression as a mood disorder causing persistent sadness and loss of interest. It then discusses several theories of depression's causes. Symptoms include changes in sleep, appetite, and thoughts of suicide. Depression is diagnosed based on symptoms lasting over a month and may be caused by medical or psychiatric conditions. Treatment involves psychotherapy, antidepressant medications like SSRIs and SNRIs, or older medications like TCAs and MAOIs. The document focuses on the mechanisms and side effects of various classes of antidepressants.
Depression is associated with feelings of sadness, loss of interest, and sleep disturbances. It involves decreased levels of monoamines like serotonin, norepinephrine, and dopamine in the brain. Common antidepressant drug classes include tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase A (MAO-A) inhibitors. Antidepressants work by inhibiting the reuptake or breakdown of neurotransmitters like serotonin and norepinephrine. They are used to treat conditions like depression, anxiety disorders, OCD, and chronic pain.
This document discusses advanced therapies for the treatment of depression. It begins by defining depression and describing its symptoms. It then covers various classifications of antidepressant drugs including SSRIs, SNRIs, and atypical antidepressants. The document discusses the mechanisms of action of these drugs in increasing serotonin and norepinephrine. It provides examples of commonly used antidepressants and their dosages. Newer drugs and non-drug therapies for depression are also summarized, including augmentation therapy, psychological therapies, and complementary/alternative medicines. The document concludes by stating that augmentation therapy can be used when conventional antidepressants are not fully effective.
Postpartum care involves monitoring for common medical complications like headaches, hemorrhoids, varicose veins, and vulvar edema. It also addresses mental health issues such as postpartum blues, depression, and psychosis. Counseling is provided on breastfeeding, sexuality, and contraception. The routine postpartum visit at 4-6 weeks involves patient education, maternal monitoring, laboratory tests, breastfeeding support, perineal care, and prevention of complications like venous thrombosis.
An outbreak of measles occurred in 2018, with 292 cases reported across 26 states. Measles is highly contagious and spreads through the air via respiratory droplets. Those at highest risk are unvaccinated children and individuals. An investigation into the outbreak followed 13 steps: establishing the diagnosis, constructing a case definition, finding cases, descriptive analysis to generate hypotheses, evaluating hypotheses, refining hypotheses based on additional studies, implementing control measures like isolation and immunization, maintaining surveillance, and communicating findings. The outbreak was likely due to increased travel and declining vaccination rates in some communities.
Effevtivness of problem solving therapyطالبه جامعيه
Problem solving therapy is an effective treatment approach that helps patients address problems in their lives. It involves defining problems, generating and implementing solutions, and evaluating outcomes. Resources for learning more about problem solving therapy include a treatment manual by Nezu, Nezu and D'Zurilla, as well as articles on the Royal Australian College of General Practitioners and Australian National University websites that discuss its use and effectiveness.
This document discusses approaches to diagnosing and treating attention-deficit/hyperactivity disorder (ADHD) in children. It provides recommendations from the American Academy of Pediatrics, including that primary care clinicians should initiate an evaluation for ADHD if a child ages 6-12 presents with inattention, hyperactivity, impulsivity, academic issues or behavioral problems. The assessment of ADHD requires evidence from parents, teachers and clinicians, and should include evaluating for coexisting conditions. Treatment often involves medication management and coordination of care, with the goal of improving the child's educational and psychosocial development.
Approach to breast lump pain, nipple dischargeطالبه جامعيه
The document provides guidance on evaluating breast lumps, pain, and nipple discharge. It discusses:
1) Defining breast lumps and assessing risk factors for breast cancer through history, physical exam, imaging and tissue sampling.
2) Evaluating breast pain by differentiating cyclical from non-cyclical pain and considering extramammary sources through history and physical exam.
3) Distinguishing benign from suspicious nipple discharge based on characteristics like spontaneity, color, presence of a mass and laterality obtained through history and physical exam.
1. A stroke occurs when blood flow to the brain is interrupted, either by a blood clot blocking a vessel (ischemic stroke) or a blood vessel rupturing (hemorrhagic stroke).
2. The main types of ischemic strokes are caused by blood clots forming in arteries (thrombosis) or traveling from another part of the body (embolism). Hemorrhagic strokes are either subarachnoid hemorrhages or intracerebral hemorrhages.
3. Treatment for ischemic strokes involves clot-busting drugs or surgery to remove clots, while hemorrhagic strokes focus on controlling bleeding, blood pressure, and complications. The goals are
This document discusses esophageal atresia, beginning with the embryology and classification. Esophageal atresia occurs in approximately 1 in 2500-3000 live births, and is slightly more common in males. It can be associated with other anomalies. The classification system describes types A through E, with type C being most common. Prenatal diagnosis is suggested by polyhydramnios and absent stomach bubble on ultrasound. Postnatal diagnosis involves x-rays and other imaging. Treatment involves surgically closing the tracheoesophageal fistula and reconnecting the esophagus.
A 4-year-old Saudi male presented with a 1-month history of a left-sided abdominal mass and recent dysuria and gross hematuria. Examination revealed a 6x7 cm smooth, firm, oval mass in the left upper quadrant. Differential diagnoses included Wilms tumor, mesoblastic nephroma, renal cell carcinoma, clear cell sarcoma of the kidney, rhabdoid tumor of the kidney, hydronephrosis, polycystic kidney disease, and renal hemorrhage. Imaging and biopsy were planned to determine the diagnosis.
Effect of Nifedipine Versus Telmisartan on Prevention of Atrial Fibrillation ...طالبه جامعيه
This study compared the effects of nifedipine-based versus telmisartan-based antihypertensive treatment on the prevention of atrial fibrillation recurrence in 149 hypertensive patients with paroxysmal atrial fibrillation. Both treatments successfully lowered blood pressure to the target level. However, telmisartan was more effective at preventing progression to persistent atrial fibrillation, likely by reducing left ventricular hypertrophy and left atrial remodeling to a greater extent than nifedipine. Overall rates of atrial fibrillation recurrence were similar between the groups. The study provides evidence that telmisartan may be superior to nifedipine for preventing the worsening of
1. The document discusses the pupil, normal pupil reactions, and various abnormalities of the pupil.
2. It describes tests like direct light response, swinging flashlight, and accommodation response that are used to assess the pupil.
3. Abnormalities are categorized based on whether they cause isocoria (equal pupil size) or anisocoria (unequal pupil size). Disorders causing isocoria include Argyll Robertson Pupil and Parinaud Oculoglandular Syndrome. Disorders causing anisocoria include Complete Oculomotor Palsy, Tonic Pupil, and Horner Syndrome.
This document discusses radio-ulnar synostosis, a rare condition where the radius and ulna bones of the forearm are fused together. It can be congenital, occurring during early development, or post-traumatic, caused by a forearm fracture. Symptoms include limited rotation of the forearm and pain. Diagnosis is made through x-rays showing the fused bones. Treatment depends on the severity but may include surgery to separate the bones followed by splinting and physical therapy.
Diabetic neuropathy is nerve damage that can occur from diabetes. It is characterized by progressive loss of nerve function. The most common type is peripheral neuropathy, which often affects the lower limbs first before moving up. Symptoms depend on the nerves affected but usually include numbness, tingling, or pain in the feet. Investigations help identify the type of neuropathy and treatments aim to control blood sugar levels, care for the feet, and manage pain through medications.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
3. 2- Tricyclic antidepressants (TCAs)
such as imipramine (Tofranil) and nortriptyline
(Pamelor).
3- Monoamine oxidase inhibitors (MAOIs)
such as tranylcypromine
(Parnate) and
phenelzine (Nardil).
MAOIs are often
useful in
treatment of
“atypical”
depression.
4. 4- Norepinephrine and dopamine reuptake
inhibitors (NDRIs)
Bupropion (Wellbutrin).
5- Atypical antidepressants
include trazodone, mirtazapine (Remeron) and
vilazodone .
5. 6- Serotonin and Noradrenalin Reuptake
Inhibitors (SNRIs)
includes venlafaxine; desvenlafaxine; duloxetine.
7- Reversible Inhibitors of MonoAmine oxidase
(RIMAs)
Moclobemide.
6. 8- Noradrenaline-Serotonin Specific
Antidepressants (NaSSAs)
Mirtazapine.
9- Noradrenalin Reuptake
Inhibitors (NARIs)
Reboxetine.
All antidepressant
medications are equally
effective but differ in side
effect profiles. Medications
usually take 4 to 8 weeks
to work.
8. Resources
1- First Aid for the Psychiatry Clerkship, Latha
Stead (Author), Matthew Kaufman (Author),
Jason Yanofski (Author), third edition
2- http://www.mayoclinic.org.
3-http://www.beyondblue.org.